← Open Payments lookup

RALPH LISSAUR: Open Payments

NPI 1245287960 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,006 in 52 payments from 12 companies in 2025. Trend: 2023 $1,122 · 2024 $1,003 · 2025 $1,006

Food & beverage: $1,006
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.14$253
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$157
Neurocrine BioSciences, Inc.2$143
ABBVIE INC.9$137
E.R. Squibb & Sons, L.L.C.3$65
Lundbeck LLC2$54
Alkermes, Inc.3$51
Axsome Therapeutics, Inc.2$42
Janssen Pharmaceuticals, Inc2$37
Almatica Pharma LLC2$30

Products named: REXULTI, CAPLYTA, INGREZZA, VRAYLAR, ABILIFY ASIMTUFII, COBENFY, ARISTADA, Auvelity.

Industry payments across CA — which companies pay providers there.